Federation des caisses Desjardins du Quebec Has $1.07 Million Stock Position in The Clorox Company $CLX

Federation des caisses Desjardins du Quebec lowered its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 75.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,292 shares of the company's stock after selling 22,855 shares during the quarter. Federation des caisses Desjardins du Quebec's holdings in Clorox were worth $1,074,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Ameriprise Financial Inc. grew its holdings in Clorox by 14.8% in the 4th quarter. Ameriprise Financial Inc. now owns 245,686 shares of the company's stock worth $39,902,000 after acquiring an additional 31,624 shares during the last quarter. Fiduciary Trust Co lifted its holdings in Clorox by 47.5% in the fourth quarter. Fiduciary Trust Co now owns 3,106 shares of the company's stock worth $504,000 after buying an additional 1,000 shares during the period. Ensign Peak Advisors Inc lifted its holdings in Clorox by 19.0% in the fourth quarter. Ensign Peak Advisors Inc now owns 86,194 shares of the company's stock worth $13,999,000 after buying an additional 13,745 shares during the period. Graham Capital Management L.P. purchased a new stake in Clorox in the fourth quarter worth about $1,893,000. Finally, Gotham Asset Management LLC lifted its holdings in Clorox by 145.1% in the fourth quarter. Gotham Asset Management LLC now owns 62,064 shares of the company's stock worth $10,080,000 after buying an additional 36,742 shares during the period. Institutional investors own 78.53% of the company's stock.

Insider Activity at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.57% of the company's stock.

Clorox Stock Performance

Shares of CLX traded down $0.15 during midday trading on Friday, hitting $124.26. 724,222 shares of the stock traded hands, compared to its average volume of 1,663,995. The firm has a market capitalization of $15.20 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The business's 50 day moving average price is $124.30 and its two-hundred day moving average price is $132.67. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were given a $1.24 dividend. This is a positive change from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. The ex-dividend date of this dividend was Wednesday, August 13th. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. JPMorgan Chase & Co. boosted their price target on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research report on Monday. Citigroup restated a "neutral" rating and issued a $135.00 price objective (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Morgan Stanley reduced their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. UBS Group dropped their price objective on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Finally, Wells Fargo & Company reduced their price objective on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a research report on Friday, September 5th. One investment analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat.com, Clorox presently has an average rating of "Reduce" and an average price target of $142.18.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.